Skip to main content.

Jo A. Wick, PhD

Jo Wick portrait
Professor, Biostatistics & Data Science
jwick@kumc.edu

Professional Background

Dr. Wick has more than a decade of education and experience in biostatistics, clinical trial design and analysis, Bayesian statistics, and adaptive clinical trials. Her methodological and collaborative research focuses on issues in clinical trial design, Bayesian methodology, and statistics education. She has experience in clinical and pre-clinical research environments in areas including benefit-risk analysis, response-adaptive clinical trial design, Bayesian trial design, and secondary data analysis. Dr. Wick's translational expertise is in the areas of respiratory-, cancer-, and heart failure-interventions and outcomes, health disparities, and clinical trials.

Education and Training
  • PhD, Statistics, Baylor Univ., Waco, Texas
Professional Affiliations
  • American Statistical Association, Member, 2007 - Present

Publications
  • Tang, F, Befort, C., A, Wick, J, Gajewski, B., J. 2022. Unifying the analysis of continuous and categorical measures of weight loss and incorporating group effect: a secondary re-analysis of a large cluster randomized clinical trial using Bayesian approach.. BMC medical research methodology, 22 (1), 28
  • Zhang, C, Mayo, M., S, Wick, J., A, Gajewski, B., J. 2021. Designing and analyzing clinical trials for personalized medicine via Bayesian models.. Pharmaceutical statistics
  • Tang, F, Carlson, S, Wick, J, Gajewski, B., J. 2021. Bayesian EMAX model with a mixture of normal distributions for dose-response in clinical trials.. Contemporary clinical trials, 110, 106571
  • Pal Mudaranthakam, D, Park, M, Thompson, J, Alsup, A., M, Krebill, R, Chollet Hinton, L, Hu, J, Gajewski, B, Godwin, A, Mayo, M., S, Wick, J, Harlan-Williams, L, He, J, Gurley-Calvez, T. 2021. A framework for personalized mammogram screening.. Preventive medicine reports, 23, 101446
  • Milling, T., J, Warach, S, Johnston, S., C, Gajewski, B., J, Costantini, T, Price, M, Wick, J, Roward, S, Mudaranthakam, D, Dula, A., N, King, B, Muddiman, A, Lip, G. 2021. Restart TICrH Trial Design: an adaptive randomized trial of time intervals to restart direct oral anticoagulants after traumatic intracranial hemorrhage.. Journal of neurotrauma
  • Krenzke, T, Lu, R, Mayer, M, Higgins, M, Wick, J, Cassidy, R, Sharp, J. 2021. How to succeed now and in the post-pandemic future. AMSTAT News. https://magazine.amstat.org/blog/2021/08/01/post-pandemic-future/
  • Cernik, C, Shergina, E, Thompson, J, Blackwell, K, Stephens, K, Kimminau, K., S, Wick, J, Mayo, M., S, Gajewski, B, He, J, Mudaranthakam, D., P. 2021. Non-cancer clinical trials start-up metrics at an academic medical center: Implications for advancing research.. Contemporary clinical trials communications, 22, 100774
  • Richter, K., P, Clark, L, Wick, J., A, Cruvinel, E, Durham, D, Shaw, P, Shih, G., H, Befort, C., A, Simari, R., D. 2020. Women Physicians and Promotion in Academic Medicine.. The New England journal of medicine, 383 (22), 2148-2157
  • Mudaranthakam, Dinesh., Pal, Cernik, Colin, Curtis, Leslie, Griffith, Blake, Hu, Jinxiang, Wick, Jo, Thompson, Jeffrey, Gajewski, Byron, Koestler, Devin, Jensen, Roy., A, others. 2020. Utilization of Technology to Improve Efficiency in Investigational Drug Management Processes. Journal of Pharmacy Technology, 36 (2), 84--90. https://journals.sagepub.com/doi/abs/10.1177/8755122519900049?journalCode=pmta
  • Liu, J, Wick, J, Jiang, Y, Mayo, M, Gajewski, B. 2020. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.. Pharmaceutical statistics, 19 (5), 692-709